Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study-Reference-Cited by-同舟云学术

Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study

Published:2023-08-16 Issue:1 Volume:78 Page:27-30
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Soto Caitlin L¹,Hsu Alice J¹,Lee Jae Hyoung²,Dzintars Kathryn¹,Choudhury Rebecca³,Jenkins Timothy C⁴,McCreary Erin K⁵,Quartuccio Katelyn S⁶,Stohs Erica J⁷,Zimmerman Matty¹,Tamma Pranita D²^ORCID

Affiliation:

1. Department of Pharmacy, Johns Hopkins Hospital , Baltimore, Maryland , USA

2. Department of Pediatrics, Johns Hopkins University , Baltimore, Maryland , USA

3. Department of Medicine, Montefiore Medical Center , Bronx, New York , USA

4. Department of Medicine, Denver Health , Denver, Colorado , USA

5. Department of Medicine, University of Pittsburgh School of Medicine , Pittsburgh, Pennsylvania , USA

6. Department of Pharmacy, University of Rochester Medical Center , Rochester, New York , USA

7. Department of Medicine, University of Nebraska Medical Center , Omaha, Nebraska , USA

Abstract

Abstract In a propensity-score-weighted cohort of 183 adults with carbapenem-resistant Enterobacterales bacteremia at 24 US hospitals, patients receiving short courses of active therapy (7–10 days, median 9 days) experienced similar odds of recurrent bacteremia or death within 30 days as those receiving prolonged courses of active therapy (14–21 days, median 14 days).

Funder

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad476/51516159/ciad476.pdf

Reference11 articles.

1. Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by enterobacterales: a randomized, controlled trial;Molina;Clin Microbiol Infect,2022

2. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial;von Dach;JAMA,2020

3. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial;Yahav;Clin Infect Dis,2019

4. Infectious Diseases Society of America guidance on the treatment of extended-Spectrum beta-lactamase producing enterobacterales (ESBL-E), carbapenem-resistant enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa);Tamma;Clin Infect Dis,2021

5. Epidemiology of gram-negative bloodstream infections in the United States: results from a cohort of 24 hospitals;Ince;Open Forum Infect Dis,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of short- versus prolonged-courses of antimicrobial therapy for carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A propensity score-matched cohort study;Journal of Microbiology, Immunology and Infection;2024-08

2. Evaluation of Short Versus Long Courses of Antibiotics in Critically Ill Patients With Gram-Negative Bloodstream Infections;Annals of Pharmacotherapy;2024-02-12